Journal of Hematology & Oncology

official impact factor 2.93

Open Access Highly Access

Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy

RuiRong Yuan*, Andrea Kay, William J Berg and David Lebwohl

Journal of Hematology & Oncology 2009, 2:45 doi:10.1186/1756-8722-2-45

Accesses  

  • Last 30 days: 238 accesses
  • Last 365 days: 3405 accesses
  • All time: 9962 accesses

Cited by

BioMed Central: 3 citations

Research   Open Access

Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens

Sean Kirby, Anjali Satoskar, Sergey Brodsky, Amy Pope-Harman, David Nunley, Charles Hitchcock, Ronald Pelletier, Patrick Ross, Tibor Nadasdy, Konstantin Shilo Diagnostic Pathology 2012, 7:25 (14 March 2012)

Research   Open Access

Isolation, characterization, and in vitro propagation of infantile hemangioma stem cells and an in vivo mouse model

Dan Xu, Teresa M O, Archil Shartava, Taylor C Fowles, Jianchang Yang, Louis M Fink, David C Ward, Martin C Mihm, Milton Waner, Yupo Ma Journal of Hematology & Oncology 2011, 4:54 (22 December 2011)

Review   Open Access Highly Accessed

Chemotherapy in advanced bladder cancer: current status and future

Nabil Ismaili, Mounia Amzerin, Aude Flechon Journal of Hematology & Oncology 2011, 4:35 (9 September 2011)